PERINATAL TRIALS REPORT

PTO388

Parenteral intravenous optimal treatment for hypertensive emergencies in pregnancy

Plain Language Summary:      

To optimize the intravenous treatment of hypertensive crisis in pregnancy comparing hydralazine and diazoxide.

Trial status:                         Open to accrual

Trial Objective:

Optimize bloood pressure control of diazoxide versus IV hydralazine (non-blinded) requirement for urgent delivery.

Type of administration:        Multi- centre National

Principal Investigator/s:       

A/Prof Annemarie Hennessy

Ph 61 2 9515 7653

Email: ahennese@renicu.rpa.cs.nsw.gov.au

Contact Person/s:         

A/Prof Annemarie Hennessy

Ph 61 2 9515 7653

Email: ahennese@renicu.rpa.cs.nsw.gov.au

© IMPACT/PSANZ 2001